Rheologic properties of soft tissue fillers and implications for clinical use.

cosmetic dermatology dermal filler elasticity hyaluronic acid intradermal injections rheology

Journal

Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 21 04 2020
revised: 06 05 2020
accepted: 08 05 2020
pubmed: 16 5 2020
medline: 15 5 2021
entrez: 16 5 2020
Statut: ppublish

Résumé

The use of injectable soft-tissue fillers has become an essential tool in esthetic rejuvenation. Rheology, the study of flow of matter, helps to understand the function of these products. The purpose of this article is to review the rheologic properties of soft-tissue fillers currently available in the United States and to evaluate how these properties relate to clinical performance. This article explains basic rheologic terms and describes how rheologic properties of specific soft-tissue fillers affect filler performance. The currently available soft-tissue fillers have unique rheologic and physicochemical properties that influence performance and cosmetic outcome. These properties determine that filler product is most appropriate based on degree of soft-tissue defect and anatomic location. It is imperative for physicians to have an in-depth understanding of the rheologic properties of soft-tissue fillers in order to appropriately select and utilize these products for the desired cosmetic outcome.

Sections du résumé

BACKGROUND BACKGROUND
The use of injectable soft-tissue fillers has become an essential tool in esthetic rejuvenation. Rheology, the study of flow of matter, helps to understand the function of these products.
AIMS OBJECTIVE
The purpose of this article is to review the rheologic properties of soft-tissue fillers currently available in the United States and to evaluate how these properties relate to clinical performance.
METHODS METHODS
This article explains basic rheologic terms and describes how rheologic properties of specific soft-tissue fillers affect filler performance.
RESULTS RESULTS
The currently available soft-tissue fillers have unique rheologic and physicochemical properties that influence performance and cosmetic outcome. These properties determine that filler product is most appropriate based on degree of soft-tissue defect and anatomic location.
CONCLUSION CONCLUSIONS
It is imperative for physicians to have an in-depth understanding of the rheologic properties of soft-tissue fillers in order to appropriately select and utilize these products for the desired cosmetic outcome.

Identifiants

pubmed: 32413205
doi: 10.1111/jocd.13487
doi:

Substances chimiques

Dermal Fillers 0
Hyaluronic Acid 9004-61-9

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

28-34

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Fagien S, Bertucci V, von Grote E, Mashburn JH. Rheologic and physicochemical properties used to differentiate injectable hyaluronic acid filler products. Plast Reconstr Surg. 2019;143:707-720.
International Society of Aesthetic Plastic Surgery. ISAPS global statistics. http.www.isaps.org/news/isaps-global-statistics. Accessed February 1, 2019
Michaud T. Rheology of hyaluronic acid and dynamic facial rejuvenation: topographical specificities. J Cosmet Dermatol. 2018;17:736-743.
Pierre S, Liew S, Berardin A. Basics of dermal filler rheology. Dermatol Surg. 2015;41:S120-S126.
Tezel A, Fredrickson GH. The science of hyaluronic acid fillers. J Cosmet Laser Ther. 2008;10:35-42.
Fallacara A, Manfredini S, Durini E, Vertuani S. Hyaluronic acid fillers in soft tissue regeneration. Facial Plast Surg. 2017;33:87-96.
Kablik J, Monheit GD, Yu L, et al. Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg. 2009;35(Suppl 1):302-312.
Sundaram H, Cassuto D. Biophysical characteristics of hyaluronic acid soft-tissue fillers and their relevance to aesthetic applications. Plast Reconstr Surg. 2013;132:5S-21S.
Sundaram H, Rohrich RJ, Liew S, et al. Cohesivity of hyaluronic acid fillers: development and clinical implications of a novel assay, pilot validation with a five-point grading scale, and evaluation of six U.S. Food and Drug Administration-approved fillers. Plast Reconstr Surg. 2015;136:678-686.
Sundaram H, Voigts B, Beer K, Meland M. Comparison of the rheological properties of viscosity and elasticity in two tissue fillers: calcium hydroxylapatite and hyaluronic acid. Dermatol Surg. 2010;36:1859-1865.
US Food and Drug Administration. Soft tissue fillers approved by the center for devices and radiological health. 2017. https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/CosmeticDevices/WrinkleFillers/ucm227749.htm. Accessed June 27, 2018
Carruthers J, Carruthers A, Tezel A, et al. Volumizing with a 20-mg/mL smooth, highly cohesive, viscous hyaluronic acid filler and its role in facial rejuvenation therapy. Dermatol Surg. 2010;36(Suppl 3):1886-1892.
Sadeghpour M, Quatrano NA, Bonati LM, et al. Delayed-onset nodules to differentially crosslinked hyaluronic acids: comparative incidence and risk assessment. Dermatol Surg. 2019;45:1085-1094.
Rzany B, Bayerl C, Bodokh I, et al. Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, evaluator- blinded, intra-individual comparison study. J Cosmet Laser Ther. 2011;13:107-112.
Solish N, Bertucci V, Percec I, et al. Dynamics of hyaluronic acid fillers formulated to maintain natural facial expression. J Cosmet Dermatol. 2019;18:738-746.
Swift A, von Grote E, Jonas B, Nogueira A. Minimal recovery time needed to return to social engagement following nasolabial fold correction with hyaluronic acid fillers produced with XpresHAn technology. Clin Cosmet Investig Dermatol. 2017;10:229-238.
Jones D, Flynn T. Hyaluronic acids: clinical applications. In: Jones D, eds. Injectable fillers: principles and practice. Chichester, UK: Wiley-Blackwell; 2010:158-174.
Wang F, Garza LA, Kang S, et al. In vivo stimulation of a de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol. 2007;143:155-163.
Turlier V, Delalleau A, Casas C, et al. Association between collagen production and mechanical stretching in dermal extracellular matrix: in vivo effect of cross-linked hyaluronic acid filler. A randomised, placebo-controlled study. J Dermatol Sci. 2013;69:187-194.
Carruthers JDA, Carruthers JA, Humphrey S. Fillers and neocollagenesis. Dermatol Surg. 2014;40:S134-S136.
America, Inc.. RADIESSE injectable implant [instructions for use]. Franksville, WI: Merz North. America, Inc.; 2013.
Hee CK, Shumate GT, Narurkar V, et al. Rheologic properties and in vivo performance characteristics of soft tissue fillers. Dermatol Surg. 2015;41:S373-S381.
Breithaupt A, Fitzgerald R. Collagen stimulators: poly-L-lactic acid and calcium hydroxyl apatite. Facial Plast Surg Clin N Arm. 2015;23:459-469.
Berlin AL, Hussain M, Goldberg DJ. Calcium hydoxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis. Dermatol Surg. 2008;34(Suppl 1):S64-S67.
Moers-Carpi M, Vogt S, Santos BM, et al. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. Dermatol Surg. 2007;33(Suppl 2):S144-S151.
Galderma Laboratories. SCULPTRA® Aesthetic (injectable poly-L-lactic acid) [instructions for use]. Fort Worth, TX: Galderma Laboratories; 2016.
Vleggaar D, Fitzgerald R, Lorenc ZP. Composition and mechanism of action of poly-L-lactic acid in soft tissue augmentation. J Drugs Dermatol. 2014;13(4 Suppl):s29-s31.
Vleggaar D. Facial volumetric correction with injectable poly-l-lactic acid. Dermatol Surg. 2005;31:1511-1517.
Fitzgerald R, Bass LM, Goldberg DJ, et al. Physiochemical characteristics of poly-l-lactic acid (PLLA). Aesthetic Surg J. 2015;38(S1):S13-S17.
Fitzgerald R, Vleggaar D. Facial volume restoration of the aging face with poly-l-lactic acid. Dermatol Ther. 2011;24(1):2-27.
Narins RS, Baumann L, Brandt FS, et al. A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. J Am Acad Dermatol. 2010;62(3):448-462.
Lemperle G, Knapp TR. Artefill permanent injectable for soft tissue augmentation: I. mechanism of action and injection techniques. Aesth Plast Surg. 2010;34:264-272.
Lemperle G, Gauthier-Hazan N, Wolters M, et al. Foreign body granulomas after all injectable dermal fillers. Part 1: possible causes. Plast Reconstr Surg. 2009;123:1842-1863.
Lemperle G, de Fazio S, Nicolau P. ArteFill: a third-generation permanent dermal filler and tissue stimulator. Clin Plast Surg. 2006;33(4):551-565.
Gold MH, Sadick NS. Optimizing outcomes with polymethylmethacrylate fillers. J Cosmet Dermatol. 2018;17:298-304.
Karnik J, Baumann L, Bruce S, et al. A double-blind, randomized, multicenter, controlled trial of suspended polymethylmethacrylate microspheres for the correction of atrophic facial acne scars. J Am Acad Dermatol. 2014;71:77-83.
Mills DC, Camp S, Mosser S, et al. Malar augmentation with a polymethylmethacrylate-enhanced filler: assessment of a 12-month open-label pilot study. Aesthet Surg J. 2013;33:421-430.
Mani N, McLeod J, Sauder MB, et al. Novel use of polymethyl methacrylate (PMMA) microspheres in the treatment of infraorbital rhytids. J Cosmet Dermatol. 2013;12:275-280.
Rivkin A. A prospective study of non-surgical primary rhinoplasty using a polymethylmethacrylate injectable implant. Dermatol Surg. 2014;40:305-313.
Cohen S, Dover J, Monheit G, et al. Five-year safety and satisfaction study of PMMA-collagen in the correction of nasolabial folds. Dermatol Surg. 2015;41(Suppl 1):S302-S313.
Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg. 2003;29(6):573-587.
Smith KC, Melnychuk M. Five percent lidocaine cream applied simultaneously to the skin and mucosa of the lips creates excellent anesthesia for filler injections. Dermatol Surg. 2005;31:1635-1637.
Murray CA, Zloty D, Warshawski L. The evolution of soft tissue fillers in clinical practice. Dermatol Clin. 2005;23:343-363.

Auteurs

Kerry Heitmiller (K)

Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Christina Ring (C)

Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Nazanin Saedi (N)

Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH